Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
.png)
On-Demand Webinar: Outsourced Pharma Capacity Update - Drug Substance
Are you an innovative company seeking a reliable CDMO partner to help move your drug substance program to its next phase of success? Look no further.
Key Steps in the Vaccine Scale-up Journey
In this roundtable discussion, experts from Resilience will discuss key steps in getting vaccines from development to the global market. You’ll hear...
Boston, MA: Process & Analytical Development and Manufacturing Facility
The launch of our Process & Analytical Development and Manufacturing Facility marks a strategic resurgence in the Boston area, as we consolidate and...
.png)
On-Demand Webinar: Outsourced Pharma Capacity Update - Fill/Finish
Are you an innovative company seeking a reliable CDMO partner for your drug product projects? Look no further.
On-Demand Presentation: Improving cell line development in CHO with a focus on product manufacturability
With a discussion on cell line productivity and evolution, an exploration of the benefits of utilizing molecule optimization and engineering, and an...
Meet the Team: Viral Vector Development & Manufacturing
Meet Kyle Anderson, Ph.D., Director of Manufacturing Science and Technology (MSAT) at Resilience RTP, North Carolina & Xiaotong Fu, Ph.D., Head of...
